Tus Pharmaceutical Group Co Ltd (000590) — Cash Flow-to-Debt Ratio
Tus Pharmaceutical Group Co Ltd (000590) has a Cash Flow-to-Debt Ratio of 0.01x as of September 2025, meaning its operating cash flow of CN¥2.24 Million could theoretically repay 0% of its total liabilities (CN¥359.74 Million) in one year. Explore 000590 long-term asset investment ratio to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Tus Pharmaceutical Group Co Ltd Cash Flow-to-Debt Ratio (1998–2025)
Historical debt coverage capacity for Tus Pharmaceutical Group Co Ltd across 28 annual periods. Also explore Tus Pharmaceutical Group Co Ltd balance sheet assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Tus Pharmaceutical Group Co Ltd (1998–2025)
Year-by-year debt coverage analysis for Tus Pharmaceutical Group Co Ltd. For market capitalisation and broader financial context, see 000590 market cap overview.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.09x | CN¥28.96 Million | CN¥339.98 Million | ▲ +101.9% |
| 2024 | 0.04x | CN¥17.39 Million | CN¥412.18 Million | ▲ +162.8% |
| 2023 | -0.07x | CN¥-28.39 Million | CN¥422.92 Million | ▼ -157.2% |
| 2022 | 0.12x | CN¥54.47 Million | CN¥464.26 Million | ▲ +33.0% |
| 2021 | 0.09x | CN¥25.20 Million | CN¥285.50 Million | ▼ -57.6% |
| 2020 | 0.21x | CN¥51.48 Million | CN¥247.27 Million | ▲ +60.1% |
| 2019 | 0.13x | CN¥29.21 Million | CN¥224.58 Million | ▲ +4608.9% |
| 2018 | 0.00x | CN¥654.24K | CN¥236.88 Million | ▲ +100.9% |
| 2017 | -0.31x | CN¥-89.14 Million | CN¥290.40 Million | ▼ -246.2% |
| 2016 | -0.09x | CN¥-32.51 Million | CN¥366.72 Million | ▲ +44.1% |
| 2015 | -0.16x | CN¥-60.56 Million | CN¥381.64 Million | ▼ -25.5% |
| 2014 | -0.13x | CN¥-50.91 Million | CN¥402.71 Million | ▼ -968.0% |
| 2013 | 0.01x | CN¥4.12 Million | CN¥283.05 Million | ▼ -83.4% |
| 2012 | 0.09x | CN¥19.75 Million | CN¥225.44 Million | ▼ -28.6% |
| 2011 | 0.12x | CN¥30.87 Million | CN¥251.62 Million | ▼ -58.2% |
| 2010 | 0.29x | CN¥84.98 Million | CN¥289.85 Million | ▲ +144.8% |
| 2009 | 0.12x | CN¥34.14 Million | CN¥285.11 Million | ▼ -14.7% |
| 2008 | 0.14x | CN¥34.89 Million | CN¥248.53 Million | ▼ -50.2% |
| 2007 | 0.28x | CN¥68.04 Million | CN¥241.37 Million | ▲ +431.1% |
| 2006 | -0.09x | CN¥-23.33 Million | CN¥274.10 Million | ▼ -160.2% |
| 2005 | 0.14x | CN¥55.96 Million | CN¥396.04 Million | ▲ +19.3% |
| 2004 | 0.12x | CN¥48.46 Million | CN¥409.06 Million | ▲ +306.6% |
| 2003 | -0.06x | CN¥-24.43 Million | CN¥426.00 Million | ▼ -127.0% |
| 2002 | 0.21x | CN¥94.30 Million | CN¥443.96 Million | ▲ +273.4% |
| 2001 | -0.12x | CN¥-51.00 Million | CN¥416.40 Million | ▼ -481.2% |
| 2000 | 0.03x | CN¥8.23 Million | CN¥256.24 Million | ▲ +177.3% |
| 1999 | -0.04x | CN¥-10.35 Million | CN¥249.06 Million | ▼ -244.8% |
| 1998 | 0.03x | CN¥3.89 Million | CN¥135.56 Million | — |